Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
MetadataShow full item record
Other Language Versions
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV. Although the burden of disease is concentrated in the Americas, the recommendations presented within these guidelines are applicable globally. These guidelines were produced in accordance with the World Health Organization (WHO) handbook for guideline development. The Guideline Development Group elaborated the final recommendations based on a systematic review of scientific literature and critical evaluation of the evidence available using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. These guidelines are intended for health-care providers, HIV program managers, policy-makers, national treatment advisory boards, researchers, and other professionals involved in caring for people who either have or may be at risk of developing disseminated histoplasmosis.© Pan American Health Organization and World Health Organization, 2020 PAHO ISBN: 978-92-75-12248-8 (Print) WHO ISBN: 978-92-4-000644-7 (Print) PAHO ISBN: 978-92-75-12249-5 (PDF) WHO ISBN: 978-92-4-000643-0 (PDF)
Directrices para el diagnóstico y el manejo de la histoplasmosis diseminada en las personas con infección por el VIH
Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV. Washington, D.C.: Pan American Health Organization and World Health Organization; 2020. License: CC BY-NC-SA 3.0 IGO.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Technical specifications of medical devices for the case management of COVID-19 in healthcare settings. Interim recommendations, 3 March 2020 Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2020-03-03)• In December 2019 a novel coronavirus (SARS-CoV-2) was identified as the causative agent of pneumonia (COVID-19) among people exposed to a seafood market in Wuhan, China. • There are gaps in the knowledge about the natural ...
Organización Panamericana de la Salud (Washington, D.C., OPS, 2018-11)Objetivos: Esta guía está enfocada en emitir recomendaciones para el diagnóstico y el tratamiento de la enfermedad de Chagas, como infección por Trypanosoma cruzi, agente protozoario de una parasitosis sistémica. Metodología: ...
Guidelines for care of critically ill adult patients with COVID-19 in the Americas. Short version, v.2, 29 July 2020 Pan American Health Organization; Evidence and Intelligence for Action in Health (EIH) (Washington, D.C., PAHO, 2020-08-26)These clinical practice guidelines (short version) were developed in order to provide recommendations for the management of critically ill adult patients with COVID-19 treated in intensive care units (ICUs). These clinical ...